Skip to main content
logo
Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
33.21
+0.84 (2.61%)
Mar 4, 2026, 12:52 PM EST - Market open

Immunocore Holdings Revenue

In the year 2025, Immunocore Holdings had annual revenue of $400.02M with 28.95% growth. Immunocore Holdings had revenue of $104.48M in the quarter ending December 31, 2025, with 24.30% growth.

Revenue (ttm)
$400.02M
Revenue Growth
+28.95%
P/S Ratio
4.18
Revenue / Employee
$763,389
Employees
524
Market Cap
1.68B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025400.02M89.81M28.95%
Dec 31, 2024310.20M60.77M24.37%
Dec 31, 2023249.43M75.07M43.05%
Dec 31, 2022174.36M137.88M377.91%
Dec 31, 202136.48M-4.63M-11.26%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sarepta Therapeutics2.20B
Harmony Biosciences Holdings868.45M
Innoviva411.33M
Nurix Therapeutics83.98M
Intellia Therapeutics67.67M
Agios Pharmaceuticals54.03M
Oculis Holding AG992.00K
Revenue Rankings

IMCR News

More News